| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.922 | 0.002 | 0.922 | Vasodilator, peripheral | 0.909 0.003 DB12406 0.909 0.003 DBMET03229 0.909 0.003 DBMET03232 0.901 0.003 DBMET03233 0.763 0.004 DBMET03234 0.921 0.002 DBMET03230 0.872 0.003 DBMET03231 0.731 0.005 DBMET03235 | ||
| 0.904 | 0.002 | 0.926 | Cyclic AMP phosphodiesterase inhibitor | 0.922 0.001 DB12406 0.922 0.001 DBMET03229 0.804 0.002 DBMET03232 0.804 0.002 DBMET03233 0.908 0.001 DBMET03234 0.875 0.002 DBMET03230 0.829 0.002 DBMET03231 0.926 0.001 DBMET03235 | DBMET03235 | |
| 0.645 | 0.009 | 0.752 | Spasmolytic | 0.751 0.005 DB12406 0.751 0.005 DBMET03229 0.639 0.01 DBMET03232 0.633 0.01 DBMET03233 0.447 0.031 DBMET03234 0.752 0.005 DBMET03230 0.592 0.014 DBMET03231 0.584 0.015 DBMET03235 | DBMET03230 | |
| 0.597 | 0.005 | 0.7 | Diuretic | 0.542 0.006 DB12406 0.542 0.006 DBMET03229 0.694 0.004 DBMET03232 0.7 0.004 DBMET03233 0.554 0.005 DBMET03234 0.575 0.005 DBMET03230 0.549 0.005 DBMET03231 0.497 0.008 DBMET03235 | DBMET03233 | |
| 0.59 | 0.006 | 0.59 | Vasodilator | 0.582 0.007 DB12406 0.582 0.007 DBMET03229 0.551 0.009 DBMET03232 0.55 0.009 DBMET03233 0.496 0.012 DBMET03234 0.559 0.008 DBMET03230 0.545 0.009 DBMET03231 0.497 0.012 DBMET03235 | ||
| 0.576 | 0.007 | 0.786 | Psychostimulant | 0.569 0.007 DB12406 0.569 0.007 DBMET03229 0.786 0.004 DBMET03232 0.755 0.004 DBMET03233 0.482 0.013 DBMET03234 0.489 0.012 DBMET03230 0.494 0.011 DBMET03231 0.477 0.013 DBMET03235 | DBMET03232 | |
| 0.562 | 0.004 | 0.562 | Bronchodilator | 0.513 0.004 DB12406 0.513 0.004 DBMET03229 0.488 0.005 DBMET03232 0.492 0.005 DBMET03233 0.551 0.004 DBMET03234 0.463 0.005 DBMET03230 0.433 0.005 DBMET03231 0.505 0.005 DBMET03235 | ||
| 0.549 | 0.003 | 0.549 | TRPA1 antagonist | 0.337 0.004 DB12406 0.337 0.004 DBMET03229 0.267 0.004 DBMET03232 0.262 0.004 DBMET03233 0.231 0.005 DBMET03234 0.219 0.005 DBMET03230 0.267 0.004 DBMET03231 0.096 0.018 DBMET03235 | ||
| 0.521 | 0.02 | 0.636 | Immunomodulator | 0.636 0.009 DB12406 0.636 0.009 DBMET03229 0.562 0.015 DBMET03232 0.55 0.017 DBMET03233 0.304 0.08 DBMET03234 0.607 0.011 DBMET03230 0.592 0.012 DBMET03231 0.491 0.024 DBMET03235 | DBMET03229 | |
| 0.53 | 0.074 | 0.53 | DNA directed DNA polymerase inhibitor | 0.396 0.117 DB12406 0.396 0.117 DBMET03229 0.403 0.114 DBMET03232 0.421 0.107 DBMET03233 0.456 0.095 DBMET03234 0.408 0.112 DBMET03230 0.291 0.166 DBMET03231 0.329 0.148 DBMET03235 | ||
| 0.446 | 0.004 | 0.529 | Adenosine A1 receptor antagonist | 0.455 0.004 DB12406 0.455 0.004 DBMET03229 0.402 0.004 DBMET03232 0.418 0.004 DBMET03233 0.517 0.003 DBMET03234 0.361 0.005 DBMET03230 0.364 0.005 DBMET03231 0.529 0.003 DBMET03235 | DBMET03235 | |
| 0.473 | 0.033 | 0.592 | Antithrombotic | 0.582 0.018 DB12406 0.582 0.018 DBMET03229 0.592 0.017 DBMET03232 0.568 0.02 DBMET03233 0.282 0.101 DBMET03234 0.585 0.018 DBMET03230 0.435 0.041 DBMET03231 0.384 0.053 DBMET03235 | DBMET03232 | |
| 0.471 | 0.041 | 0.471 | Immunosuppressant | 0.398 0.064 DB12406 0.398 0.064 DBMET03229 0.366 0.078 DBMET03232 0.347 0.088 DBMET03233 0.395 0.065 DBMET03234 0.389 0.068 DBMET03230 0.371 0.076 DBMET03231 0.324 0.101 DBMET03235 | ||
| 0.427 | 0.003 | 0.498 | Adenosine A2b receptor antagonist | 0.279 0.004 DB12406 0.279 0.004 DBMET03229 0.298 0.004 DBMET03232 0.33 0.003 DBMET03233 0.498 0.002 DBMET03234 0.239 0.004 DBMET03230 0.268 0.004 DBMET03231 0.327 0.003 DBMET03235 | DBMET03234 | |
| 0.447 | 0.024 | 0.751 | Vasodilator, coronary | 0.671 0.005 DB12406 0.671 0.005 DBMET03229 0.579 0.009 DBMET03232 0.586 0.008 DBMET03233 0.333 0.064 DBMET03234 0.751 0.004 DBMET03230 0.633 0.006 DBMET03231 0.524 0.013 DBMET03235 | DBMET03230 | |
| 0.419 | 0.003 | 0.419 | Phosphodiesterase I inhibitor | 0.289 0.005 DB12406 0.289 0.005 DBMET03229 0.315 0.004 DBMET03232 0.325 0.004 DBMET03233 0.404 0.003 DBMET03234 0.286 0.005 DBMET03230 0.263 0.006 DBMET03231 0.276 0.005 DBMET03235 | ||
| 0.408 | 0.004 | 0.436 | Adenosine A2 receptor antagonist | 0.373 0.004 DB12406 0.373 0.004 DBMET03229 0.333 0.005 DBMET03232 0.351 0.004 DBMET03233 0.436 0.004 DBMET03234 0.285 0.006 DBMET03230 0.3 0.005 DBMET03231 0.397 0.004 DBMET03235 | DBMET03234 | |
| 0.346 | 0.005 | 0.346 | Mediator release inhibitor | 0.171 0.021 DB12406 0.171 0.021 DBMET03229 0.293 0.008 DBMET03232 0.268 0.009 DBMET03233 0.159 0.025 DBMET03234 0.173 0.02 DBMET03230 0.135 0.036 DBMET03231 0.096 0.075 DBMET03235 | ||
| 0.339 | 0.004 | 0.356 | Adenosine A2a receptor antagonist | 0.325 0.005 DB12406 0.325 0.005 DBMET03229 0.307 0.005 DBMET03232 0.323 0.005 DBMET03233 0.356 0.004 DBMET03234 0.26 0.007 DBMET03230 0.267 0.006 DBMET03231 0.342 0.004 DBMET03235 | DBMET03234 | |
| 0.371 | 0.038 | 0.409 | Hypoxia-inducible factor 1 alpha inhibitor | 0.29 0.07 DB12406 0.29 0.07 DBMET03229 0.379 0.036 DBMET03232 0.409 0.028 DBMET03233 0.363 0.041 DBMET03234 0.293 0.069 DBMET03230 0.27 0.084 DBMET03231 0.283 0.074 DBMET03235 | DBMET03233 | |
| 0.328 | 0.01 | 0.328 | Acetylcholine M1 receptor antagonist | 0.251 0.025 DB12406 0.251 0.025 DBMET03229 0.237 0.029 DBMET03232 0.23 0.031 DBMET03233 0.262 0.022 DBMET03234 0.21 0.038 DBMET03230 0.209 0.039 DBMET03231 0.186 0.049 DBMET03235 | ||
| 0.308 | 0.001 | 0.308 | Adenosine uptake inhibitor | 0.064 0.003 DB12406 0.064 0.003 DBMET03229 0.076 0.003 DBMET03232 0.071 0.003 DBMET03233 0.167 0.002 DBMET03234 0.062 0.004 DBMET03230 0.054 0.004 DBMET03231 0.044 0.007 DBMET03235 | ||
| 0.287 | 0.02 | 0.287 | Tumour necrosis factor antagonist | 0.211 0.047 DB12406 0.211 0.047 DBMET03229 0.263 0.027 DBMET03232 0.273 0.024 DBMET03233 0.205 0.051 DBMET03234 0.217 0.044 DBMET03230 0.18 0.067 DBMET03231 0.146 0.105 DBMET03235 | ||
| 0.238 | 0.007 | 0.253 | Interleukin 8 antagonist | 0.138 0.042 DB12406 0.138 0.042 DBMET03229 0.253 0.005 DBMET03232 0.247 0.006 DBMET03233 0.165 0.026 DBMET03234 0.142 0.04 DBMET03230 0.116 0.067 DBMET03231 | DBMET03232 | |
| 0.232 | 0.008 | 0.407 | Adenosine A3 receptor antagonist | 0.228 0.008 DB12406 0.228 0.008 DBMET03229 0.222 0.008 DBMET03232 0.23 0.008 DBMET03233 0.407 0.004 DBMET03234 0.155 0.012 DBMET03230 0.153 0.012 DBMET03231 0.404 0.004 DBMET03235 | DBMET03234 | |
| 0.228 | 0.006 | 0.355 | DNA repair enzyme inhibitor | 0.202 0.008 DB12406 0.202 0.008 DBMET03229 0.343 0.004 DBMET03232 0.355 0.004 DBMET03233 0.178 0.014 DBMET03234 0.207 0.008 DBMET03230 0.192 0.01 DBMET03231 0.163 0.021 DBMET03235 | DBMET03233 | |
| 0.216 | 0.006 | 0.488 | Electrolyte absorption antagonist | 0.314 0.004 DB12406 0.314 0.004 DBMET03229 0.451 0.003 DBMET03232 0.488 0.002 DBMET03233 0.122 0.035 DBMET03234 0.259 0.005 DBMET03230 0.314 0.004 DBMET03231 0.171 0.013 DBMET03235 | DBMET03233 | |
| 0.23 | 0.036 | 0.23 | Histone acetyltransferase inhibitor | 0.177 0.104 DB12406 0.177 0.104 DBMET03229 0.201 0.067 DBMET03232 0.201 0.068 DBMET03233 0.188 0.087 DBMET03234 | ||
| 0.263 | 0.074 | 0.432 | Cardiotonic | 0.432 0.023 DB12406 0.432 0.023 DBMET03229 0.31 0.052 DBMET03232 0.321 0.048 DBMET03233 0.275 0.067 DBMET03234 0.377 0.033 DBMET03230 0.312 0.051 DBMET03231 0.432 0.024 DBMET03235 | DBMET03235 | |
| 0.266 | 0.09 | 0.405 | Immunostimulant | 0.405 0.048 DB12406 0.405 0.048 DBMET03229 0.374 0.058 DBMET03232 0.354 0.063 DBMET03233 0.167 0.141 DBMET03234 0.387 0.054 DBMET03230 0.377 0.056 DBMET03231 0.329 0.071 DBMET03235 | DBMET03229 | |
| 0.227 | 0.054 | 0.316 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.227 0.054 DB12406 0.227 0.054 DBMET03229 0.314 0.019 DBMET03232 0.316 0.019 DBMET03233 0.162 0.123 DBMET03234 0.194 0.077 DBMET03230 0.203 0.07 DBMET03231 0.162 0.123 DBMET03235 | DBMET03233 | |
| 0.192 | 0.026 | 0.192 | Acetylcholine muscarinic antagonist | 0.115 0.072 DB12406 0.115 0.072 DBMET03229 0.116 0.071 DBMET03232 0.111 0.077 DBMET03233 0.139 0.051 DBMET03234 0.098 0.093 DBMET03230 | ||
| 0.289 | 0.124 | 0.328 | GABA C receptor rho-3 antagonist | 0.291 0.122 DBMET03232 0.328 0.098 DBMET03233 0.305 0.112 DBMET03234 | DBMET03233 | |
| 0.161 | 0.009 | 0.179 | Phosphodiesterase 5A inhibitor | 0.132 0.015 DB12406 0.132 0.015 DBMET03229 0.17 0.008 DBMET03232 0.179 0.007 DBMET03233 0.168 0.009 DBMET03234 0.13 0.015 DBMET03230 0.124 0.017 DBMET03231 0.139 0.013 DBMET03235 | DBMET03233 | |
| 0.174 | 0.031 | 0.174 | Antibacterial (Helicobacter pylori) | 0.133 0.064 DB12406 0.133 0.064 DBMET03229 0.12 0.081 DBMET03232 0.116 0.087 DBMET03233 0.14 0.056 DBMET03234 0.112 0.094 DBMET03230 0.107 0.104 DBMET03231 | ||
| 0.153 | 0.01 | 0.17 | Phosphodiesterase V inhibitor | 0.127 0.016 DB12406 0.127 0.016 DBMET03229 0.161 0.009 DBMET03232 0.17 0.008 DBMET03233 0.162 0.009 DBMET03234 0.125 0.017 DBMET03230 0.119 0.019 DBMET03231 0.135 0.014 DBMET03235 | DBMET03233 | |
| 0.15 | 0.007 | 0.163 | Phosphodiesterase 4C inhibitor | 0.135 0.009 DB12406 0.135 0.009 DBMET03229 0.13 0.009 DBMET03232 0.138 0.009 DBMET03233 0.163 0.006 DBMET03234 0.104 0.014 DBMET03230 0.125 0.01 DBMET03231 0.149 0.007 DBMET03235 | DBMET03234 | |
| 0.153 | 0.012 | 0.153 | Phosphodiesterase 4B inhibitor | 0.071 0.043 DBMET03232 0.083 0.034 DBMET03233 0.141 0.014 DBMET03234 0.067 0.047 DBMET03230 | ||
| 0.146 | 0.007 | 0.286 | Phosphodiesterase VI inhibitor | 0.213 0.004 DB12406 0.213 0.004 DBMET03229 0.131 0.009 DBMET03232 0.137 0.008 DBMET03233 0.17 0.005 DBMET03234 0.286 0.003 DBMET03230 0.263 0.004 DBMET03231 0.249 0.004 DBMET03235 | DBMET03230 | |
| 0.146 | 0.011 | 0.265 | Phosphodiesterase 6D inhibitor | 0.223 0.004 DB12406 0.223 0.004 DBMET03229 0.154 0.009 DBMET03232 0.154 0.009 DBMET03233 0.149 0.01 DBMET03234 0.265 0.003 DBMET03230 0.248 0.004 DBMET03231 0.23 0.004 DBMET03235 | DBMET03230 | |
| 0.141 | 0.008 | 0.141 | Phosphodiesterase 1B inhibitor | 0.097 0.015 DB12406 0.097 0.015 DBMET03229 0.13 0.009 DBMET03232 0.141 0.008 DBMET03233 0.128 0.009 DBMET03234 0.101 0.014 DBMET03230 0.085 0.02 DBMET03231 0.089 0.018 DBMET03235 | ||
| 0.151 | 0.019 | 0.151 | Phosphodiesterase 4D inhibitor | 0.133 0.023 DB12406 0.133 0.023 DBMET03229 0.14 0.021 DBMET03232 0.151 0.019 DBMET03233 0.148 0.02 DBMET03234 0.129 0.025 DBMET03230 0.12 0.028 DBMET03231 0.131 0.024 DBMET03235 | ||
| 0.221 | 0.092 | 0.31 | Tumour necrosis factor alpha release inhibitor | 0.31 0.05 DB12406 0.31 0.05 DBMET03229 0.156 0.151 DBMET03232 0.298 0.054 DBMET03230 0.203 0.106 DBMET03231 0.242 0.079 DBMET03235 | DBMET03229 | |
| 0.132 | 0.005 | 0.132 | Phosphodiesterase 1A inhibitor | 0.082 0.015 DB12406 0.082 0.015 DBMET03229 0.106 0.009 DBMET03232 0.113 0.008 DBMET03233 0.125 0.006 DBMET03234 0.078 0.017 DBMET03230 0.075 0.02 DBMET03231 0.078 0.017 DBMET03235 | ||
| 0.17 | 0.047 | 0.203 | Interleukin 1 antagonist | 0.199 0.033 DB12406 0.199 0.033 DBMET03229 0.152 0.056 DBMET03232 0.154 0.055 DBMET03233 0.203 0.031 DBMET03230 0.128 0.078 DBMET03231 0.12 0.088 DBMET03235 | DBMET03230 | |
| 0.169 | 0.047 | 0.171 | Phosphodiesterase inhibitor | 0.133 0.07 DB12406 0.133 0.07 DBMET03229 0.121 0.081 DBMET03232 0.136 0.068 DBMET03233 0.171 0.046 DBMET03234 0.133 0.07 DBMET03230 0.116 0.086 DBMET03231 0.138 0.067 DBMET03235 | DBMET03234 | |
| 0.131 | 0.011 | 0.133 | Phosphodiesterase 4A inhibitor | 0.073 0.023 DB12406 0.073 0.023 DBMET03229 0.057 0.031 DBMET03232 0.064 0.028 DBMET03233 0.133 0.011 DBMET03234 0.045 0.038 DBMET03231 0.076 0.022 DBMET03235 | DBMET03234 | |
| 0.142 | 0.023 | 0.142 | Anabolic | 0.116 0.043 DB12406 0.116 0.043 DBMET03229 0.128 0.032 DBMET03232 0.125 0.035 DBMET03233 0.093 0.073 DBMET03234 0.101 0.062 DBMET03230 0.105 0.056 DBMET03231 | ||
| 0.154 | 0.037 | 0.219 | Heat shock protein 70 antagonist | 0.161 0.026 DB12406 0.161 0.026 DBMET03229 0.219 0.005 DBMET03232 0.216 0.005 DBMET03233 0.141 0.07 DBMET03234 0.155 0.035 DBMET03230 0.152 0.042 DBMET03231 0.148 0.051 DBMET03235 | DBMET03232 | |
| 0.259 | 0.143 | 0.259 | Calpain 2 inhibitor | |||
| 0.257 | 0.142 | 0.587 | Toll-Like receptor agonist | 0.479 0.036 DB12406 0.479 0.036 DBMET03229 0.584 0.019 DBMET03232 0.587 0.019 DBMET03233 0.305 0.108 DBMET03234 0.53 0.026 DBMET03230 0.409 0.057 DBMET03231 0.504 0.031 DBMET03235 | DBMET03233 | |
| 0.159 | 0.048 | 0.159 | Cholinergic antagonist | 0.133 0.063 DBMET03234 | ||
| 0.194 | 0.083 | 0.271 | DNA methylase inhibitor | 0.188 0.087 DB12406 0.188 0.087 DBMET03229 0.271 0.038 DBMET03232 0.268 0.039 DBMET03233 0.149 0.118 DBMET03234 0.204 0.076 DBMET03230 0.146 0.121 DBMET03231 0.143 0.123 DBMET03235 | DBMET03232 | |
| 0.151 | 0.044 | 0.41 | Adenylate cyclase inhibitor | 0.301 0.013 DB12406 0.301 0.013 DBMET03229 0.292 0.014 DBMET03232 0.293 0.014 DBMET03233 0.264 0.018 DBMET03234 0.268 0.017 DBMET03230 0.273 0.017 DBMET03231 0.41 0.007 DBMET03235 | DBMET03235 | |
| 0.115 | 0.008 | 0.115 | Phosphodiesterase II inhibitor | 0.112 0.009 DB12406 0.112 0.009 DBMET03229 0.094 0.013 DBMET03232 0.097 0.012 DBMET03233 0.07 0.023 DBMET03234 0.086 0.015 DBMET03230 0.085 0.015 DBMET03231 0.071 0.023 DBMET03235 | ||
| 0.151 | 0.048 | 0.289 | DNA polymerase I inhibitor | 0.105 0.081 DB12406 0.105 0.081 DBMET03229 0.154 0.047 DBMET03232 0.141 0.054 DBMET03233 0.289 0.012 DBMET03234 0.123 0.066 DBMET03230 0.234 0.02 DBMET03235 | DBMET03234 | |
| 0.236 | 0.135 | 0.538 | Cholesterol antagonist | 0.492 0.034 DB12406 0.492 0.034 DBMET03229 0.538 0.027 DBMET03232 0.51 0.031 DBMET03233 0.526 0.028 DBMET03230 0.392 0.051 DBMET03231 0.302 0.09 DBMET03235 | DBMET03232 | |
| 0.117 | 0.016 | 0.168 | Phosphodiesterase III inhibitor | 0.099 0.023 DB12406 0.099 0.023 DBMET03229 0.095 0.025 DBMET03232 0.099 0.023 DBMET03233 0.168 0.008 DBMET03234 0.085 0.031 DBMET03230 0.066 0.046 DBMET03231 0.139 0.012 DBMET03235 | DBMET03234 | |
| 0.15 | 0.05 | 0.15 | Acetylcholine antagonist | 0.126 0.065 DBMET03234 | ||
| 0.157 | 0.059 | 0.277 | Cell wall synthesis inhibitor | 0.218 0.024 DB12406 0.218 0.024 DBMET03229 0.276 0.012 DBMET03232 0.277 0.012 DBMET03233 0.237 0.019 DBMET03230 0.191 0.034 DBMET03231 0.152 0.063 DBMET03235 | DBMET03233 | |
| 0.106 | 0.008 | 0.106 | Phosphodiesterase 2A inhibitor | 0.103 0.009 DB12406 0.103 0.009 DBMET03229 0.084 0.012 DBMET03232 0.088 0.011 DBMET03233 0.057 0.026 DBMET03234 0.077 0.015 DBMET03230 0.077 0.015 DBMET03231 0.059 0.025 DBMET03235 | ||
| 0.247 | 0.15 | 0.583 | Toll-Like receptor 7 agonist | 0.46 0.04 DB12406 0.46 0.04 DBMET03229 0.574 0.02 DBMET03232 0.583 0.019 DBMET03233 0.294 0.114 DBMET03234 0.511 0.03 DBMET03230 0.394 0.062 DBMET03231 0.486 0.034 DBMET03235 | DBMET03233 | |
| 0.174 | 0.083 | 0.265 | DNA methyltransferase I inhibitor | 0.149 0.105 DB12406 0.149 0.105 DBMET03229 0.265 0.041 DBMET03232 0.261 0.042 DBMET03233 0.149 0.105 DBMET03234 0.183 0.078 DBMET03230 | DBMET03232 | |
| 0.089 | 0.007 | 0.173 | Thymidine kinase inhibitor | 0.113 0.005 DB12406 0.113 0.005 DBMET03229 0.12 0.005 DBMET03232 0.121 0.005 DBMET03233 0.102 0.006 DBMET03234 0.173 0.003 DBMET03230 0.105 0.006 DBMET03231 0.138 0.004 DBMET03235 | DBMET03230 | |
| 0.18 | 0.099 | 0.197 | Anticonvulsant | 0.189 0.091 DBMET03232 0.197 0.085 DBMET03233 0.163 0.114 DBMET03234 | DBMET03233 | |
| 0.087 | 0.008 | 0.249 | Adenosine deaminase inhibitor | 0.225 0.002 DB12406 0.225 0.002 DBMET03229 0.124 0.004 DBMET03232 0.117 0.004 DBMET03233 0.079 0.009 DBMET03234 0.249 0.002 DBMET03230 0.153 0.003 DBMET03231 0.19 0.002 DBMET03235 | DBMET03230 | |
| 0.138 | 0.059 | 0.179 | Sphingosine 1-phosphate receptor 2 antagonist | 0.143 0.051 DB12406 0.143 0.051 DBMET03229 0.179 0.015 DBMET03232 0.17 0.021 DBMET03233 0.136 0.063 DBMET03234 0.136 0.063 DBMET03230 0.121 0.094 DBMET03231 0.141 0.055 DBMET03235 | DBMET03232 | |
| 0.102 | 0.026 | 0.114 | Caspase 7 inhibitor | 0.108 0.021 DBMET03232 0.114 0.017 DBMET03233 0.082 0.056 DBMET03234 0.077 0.068 DBMET03230 | DBMET03233 | |
| 0.219 | 0.145 | 0.285 | Thyroid hormone antagonist | 0.285 0.101 DBMET03232 0.267 0.113 DBMET03233 | DBMET03232 | |
| 0.197 | 0.127 | 0.318 | DNA synthesis inhibitor | 0.248 0.068 DB12406 0.248 0.068 DBMET03229 0.316 0.038 DBMET03232 0.314 0.039 DBMET03233 0.216 0.1 DBMET03234 0.272 0.054 DBMET03230 0.318 0.038 DBMET03231 0.274 0.053 DBMET03235 | DBMET03231 | |
| 0.119 | 0.049 | 0.119 | Electron transport complex I inhibitor | 0.108 0.067 DB12406 0.108 0.067 DBMET03229 0.11 0.062 DBMET03234 0.101 0.081 DBMET03235 | ||
| 0.083 | 0.018 | 0.09 | Phosphodiesterase 1C inhibitor | 0.067 0.033 DB12406 0.067 0.033 DBMET03229 0.086 0.015 DBMET03232 0.09 0.013 DBMET03233 0.074 0.025 DBMET03234 0.071 0.029 DBMET03230 0.062 0.044 DBMET03231 0.061 0.046 DBMET03235 | DBMET03233 | |
| 0.067 | 0.003 | 0.067 | DNA polymerase III inhibitor | 0.065 0.003 DB12406 0.065 0.003 DBMET03229 0.061 0.003 DBMET03232 0.061 0.003 DBMET03233 0.059 0.003 DBMET03234 0.063 0.003 DBMET03230 0.055 0.003 DBMET03231 0.058 0.003 DBMET03235 | ||
| 0.067 | 0.005 | 0.073 | Phosphodiesterase 6C inhibitor | 0.062 0.007 DB12406 0.062 0.007 DBMET03229 0.067 0.005 DBMET03232 0.068 0.005 DBMET03233 0.073 0.004 DBMET03234 0.061 0.008 DBMET03230 0.061 0.008 DBMET03231 0.068 0.005 DBMET03235 | DBMET03234 | |
| 0.208 | 0.147 | 0.254 | Thyroid hormone beta antagonist | 0.254 0.116 DBMET03232 0.235 0.128 DBMET03233 | DBMET03232 | |
| 0.069 | 0.009 | 0.098 | Nicotinic acid receptor agonist | 0.036 0.025 DB12406 0.036 0.025 DBMET03229 0.049 0.015 DBMET03232 0.048 0.015 DBMET03233 0.098 0.005 DBMET03234 0.058 0.012 DBMET03235 | DBMET03234 | |
| 0.214 | 0.156 | 0.214 | Transcription factor NF kappa B inhibitor | |||
| 0.068 | 0.014 | 0.145 | Nicotinic acid receptor 1 agonist | 0.066 0.014 DB12406 0.066 0.014 DBMET03229 0.083 0.01 DBMET03232 0.084 0.01 DBMET03233 0.145 0.005 DBMET03234 0.056 0.017 DBMET03230 0.058 0.017 DBMET03231 0.136 0.005 DBMET03235 | DBMET03234 | |
| 0.138 | 0.084 | 0.138 | Cytidine deaminase inhibitor | 0.114 0.108 DB12406 0.114 0.108 DBMET03229 0.138 0.084 DBMET03234 0.114 0.108 DBMET03235 | ||
| 0.057 | 0.005 | 0.079 | Phosphodiesterase 6B inhibitor | 0.049 0.007 DB12406 0.049 0.007 DBMET03229 0.058 0.005 DBMET03232 0.06 0.005 DBMET03233 0.079 0.004 DBMET03234 0.046 0.008 DBMET03230 0.047 0.008 DBMET03231 0.068 0.004 DBMET03235 | DBMET03234 | |
| 0.107 | 0.058 | 0.175 | Adenylate kinase inhibitor | 0.113 0.05 DB12406 0.113 0.05 DBMET03229 0.175 0.019 DBMET03232 0.167 0.021 DBMET03233 0.1 0.067 DBMET03234 0.104 0.061 DBMET03230 0.1 0.068 DBMET03231 0.106 0.059 DBMET03235 | DBMET03232 | |
| 0.076 | 0.03 | 0.196 | Carbamoyl phosphate synthetase inhibitor | 0.092 0.023 DB12406 0.092 0.023 DBMET03229 0.177 0.009 DBMET03232 0.196 0.008 DBMET03233 0.083 0.027 DBMET03234 0.12 0.016 DBMET03230 0.092 0.023 DBMET03231 0.099 0.021 DBMET03235 | DBMET03233 | |
| 0.094 | 0.05 | 0.098 | Phosphodiesterase IV inhibitor | 0.098 0.047 DBMET03234 | DBMET03234 | |
| 0.207 | 0.17 | 0.207 | Apoptosis antagonist | 0.207 0.17 DBMET03232 0.196 0.185 DBMET03233 | ||
| 0.153 | 0.116 | 0.313 | Interleukin antagonist | 0.313 0.045 DB12406 0.313 0.045 DBMET03229 0.26 0.058 DBMET03232 0.24 0.065 DBMET03233 0.25 0.061 DBMET03230 0.214 0.077 DBMET03231 0.238 0.066 DBMET03235 | DBMET03229 | |
| 0.176 | 0.14 | 0.234 | RNA-directed DNA polymerase inhibitor | 0.23 0.064 DB12406 0.23 0.064 DBMET03229 0.234 0.061 DBMET03232 0.234 0.061 DBMET03233 0.178 0.137 DBMET03234 0.195 0.108 DBMET03230 0.212 0.083 DBMET03231 0.232 0.063 DBMET03235 | DBMET03233 | |
| 0.043 | 0.007 | 0.043 | Calcium-independent phospholipase A2 inhibitor | 0.041 0.009 DBMET03234 | ||
| 0.052 | 0.019 | 0.066 | Dipeptidyl peptidase IV inhibitor | 0.046 0.028 DB12406 0.046 0.028 DBMET03229 0.061 0.012 DBMET03232 0.066 0.011 DBMET03233 0.041 0.04 DBMET03230 0.042 0.035 DBMET03231 | DBMET03233 | |
| 0.054 | 0.021 | 0.054 | Cytokine production stimulant | 0.05 0.03 DB12406 0.05 0.03 DBMET03229 | ||
| 0.068 | 0.038 | 0.068 | Acetylcholine M2 receptor antagonist | |||
| 0.138 | 0.109 | 0.247 | Antipruritic | 0.189 0.057 DB12406 0.189 0.057 DBMET03229 0.247 0.025 DBMET03232 0.235 0.03 DBMET03233 0.164 0.079 DBMET03230 0.141 0.106 DBMET03231 | DBMET03232 | |
| 0.033 | 0.005 | 0.038 | Phosphodiesterase 6G inhibitor | 0.03 0.008 DB12406 0.03 0.008 DBMET03229 0.034 0.005 DBMET03232 0.034 0.005 DBMET03233 0.038 0.004 DBMET03234 0.029 0.008 DBMET03230 0.029 0.008 DBMET03231 0.035 0.005 DBMET03235 | DBMET03234 | |
| 0.033 | 0.005 | 0.038 | Phosphodiesterase 6H inhibitor | 0.03 0.008 DB12406 0.03 0.008 DBMET03229 0.034 0.005 DBMET03232 0.034 0.005 DBMET03233 0.038 0.004 DBMET03234 0.029 0.008 DBMET03230 0.029 0.008 DBMET03231 0.035 0.005 DBMET03235 | DBMET03234 | |
| 0.03 | 0.003 | 0.03 | DNA polymerase III polC-type inhibitor | 0.027 0.003 DB12406 0.027 0.003 DBMET03229 0.024 0.003 DBMET03232 0.024 0.003 DBMET03233 0.027 0.003 DBMET03234 0.028 0.003 DBMET03230 0.022 0.003 DBMET03231 0.024 0.003 DBMET03235 | ||
| 0.056 | 0.031 | 0.065 | Dipeptidyl peptidase inhibitor | 0.062 0.024 DBMET03232 0.065 0.021 DBMET03233 | DBMET03233 | |
| 0.03 | 0.007 | 0.042 | Phosphodiesterase 6A inhibitor | 0.029 0.008 DB12406 0.029 0.008 DBMET03229 0.031 0.006 DBMET03232 0.031 0.006 DBMET03233 0.042 0.004 DBMET03234 0.029 0.008 DBMET03230 0.028 0.008 DBMET03231 0.039 0.004 DBMET03235 | DBMET03234 | |
| 0.1 | 0.078 | 0.203 | Mucolytic | 0.167 0.024 DB12406 0.167 0.024 DBMET03229 0.194 0.015 DBMET03232 0.203 0.013 DBMET03233 0.192 0.015 DBMET03230 0.159 0.027 DBMET03231 0.109 0.065 DBMET03235 | DBMET03233 | |
| 0.078 | 0.056 | 0.17 | Interferon agonist | 0.157 0.009 DB12406 0.157 0.009 DBMET03229 0.128 0.014 DBMET03232 0.117 0.018 DBMET03233 0.17 0.008 DBMET03230 0.164 0.009 DBMET03231 0.129 0.014 DBMET03235 | DBMET03230 | |
| 0.073 | 0.053 | 0.073 | Acetylcholine M4 receptor antagonist | |||
| 0.123 | 0.104 | 0.123 | Death-associated protein kinase 1 inhibitor | |||
| 0.078 | 0.06 | 0.131 | Histamine H1 receptor antagonist | 0.131 0.029 DBMET03232 0.13 0.029 DBMET03233 | DBMET03232 | |
| 0.032 | 0.016 | 0.035 | Purinergic P2X agonist | 0.035 0.015 DB12406 0.035 0.015 DBMET03229 0.033 0.016 DBMET03232 0.033 0.016 DBMET03233 0.032 0.016 DBMET03230 0.034 0.015 DBMET03231 0.025 0.02 DBMET03235 | DBMET03229 | |
| 0.07 | 0.056 | 0.129 | Glutamate dehydrogenase inhibitor | 0.066 0.062 DB12406 0.066 0.062 DBMET03229 0.125 0.021 DBMET03232 0.129 0.02 DBMET03233 0.076 0.049 DBMET03234 0.072 0.054 DBMET03235 | DBMET03233 | |
| 0.053 | 0.039 | 0.089 | Acyl-CoA dehydrogenase inhibitor | 0.089 0.019 DB12406 0.089 0.019 DBMET03229 0.066 0.029 DBMET03232 0.061 0.033 DBMET03233 0.08 0.022 DBMET03230 0.071 0.026 DBMET03231 0.071 0.026 DBMET03235 | DBMET03229 | |
| 0.089 | 0.075 | 0.149 | Interleukin 12 antagonist | 0.149 0.013 DB12406 0.149 0.013 DBMET03229 0.149 0.013 DBMET03232 0.146 0.014 DBMET03233 0.115 0.034 DBMET03230 0.1 0.053 DBMET03231 0.109 0.041 DBMET03235 | DBMET03232 | |
| 0.042 | 0.029 | 0.058 | Angiotensin AT1 receptor antagonist | 0.051 0.016 DB12406 0.051 0.016 DBMET03229 0.057 0.009 DBMET03232 0.058 0.008 DBMET03233 0.04 0.034 DBMET03231 0.045 0.025 DBMET03235 | DBMET03233 | |
| 0.017 | 0.005 | 0.017 | Calcium-dependent phospholipase A2 inhibitor | 0.015 0.005 DBMET03234 | ||
| 0.013 | 0.003 | 0.021 | DNA polymerase III subunit alpha inhibitor | 0.021 0.002 DB12406 0.021 0.002 DBMET03229 0.017 0.002 DBMET03232 0.016 0.002 DBMET03233 0.008 0.004 DBMET03234 0.015 0.002 DBMET03230 0.015 0.002 DBMET03231 0.014 0.002 DBMET03235 | DBMET03229 | |
| 0.086 | 0.078 | 0.146 | Interleukin 1 beta converting enzyme inhibitor | 0.143 0.02 DBMET03232 0.146 0.019 DBMET03233 | DBMET03233 | |
| 0.086 | 0.08 | 0.086 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.034 | 0.03 | 0.036 | ATM kinase inhibitor | 0.034 0.03 DBMET03232 0.036 0.025 DBMET03233 | DBMET03233 | |
| 0.024 | 0.024 | 0.031 | Thymidine phosphorylase inhibitor | 0.027 0.016 DB12406 0.027 0.016 DBMET03229 0.028 0.015 DBMET03232 0.027 0.016 DBMET03233 0.026 0.017 DBMET03234 0.031 0.011 DBMET03230 0.024 0.023 DBMET03231 0.03 0.012 DBMET03235 | DBMET03230 | |
| 0.022 | 0.025 | 0.064 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.039 0.013 DB12406 0.039 0.013 DBMET03229 0.05 0.009 DBMET03232 0.051 0.009 DBMET03233 0.044 0.011 DBMET03234 0.058 0.007 DBMET03230 0.036 0.014 DBMET03231 0.064 0.006 DBMET03235 | DBMET03235 | |
| 0.057 | 0.06 | 0.118 | Interferon inducer | 0.114 0.008 DB12406 0.114 0.008 DBMET03229 0.091 0.017 DBMET03232 0.084 0.021 DBMET03233 0.104 0.011 DBMET03230 0.118 0.008 DBMET03231 0.099 0.013 DBMET03235 | DBMET03231 | |
| 0.077 | 0.081 | 0.155 | NADH dehydrogenase inhibitor | 0.119 0.029 DB12406 0.119 0.029 DBMET03229 0.13 0.024 DBMET03232 0.143 0.019 DBMET03233 0.088 0.06 DBMET03234 0.155 0.016 DBMET03230 0.119 0.029 DBMET03231 0.135 0.022 DBMET03235 | DBMET03230 | |
| 0.018 | 0.022 | 0.029 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.022 0.012 DB12406 0.022 0.012 DBMET03229 0.022 0.011 DBMET03232 0.024 0.008 DBMET03233 0.024 0.008 DBMET03234 0.026 0.006 DBMET03230 0.022 0.012 DBMET03231 0.029 0.005 DBMET03235 | DBMET03235 | |
| 0.024 | 0.028 | 0.043 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.03 0.012 DB12406 0.03 0.012 DBMET03229 0.028 0.014 DBMET03232 0.029 0.013 DBMET03233 0.029 0.012 DBMET03234 0.043 0.004 DBMET03230 0.028 0.015 DBMET03231 0.036 0.006 DBMET03235 | DBMET03230 | |
| 0.03 | 0.034 | 0.046 | Angiotensin II receptor antagonist | 0.038 0.017 DB12406 0.038 0.017 DBMET03229 0.045 0.009 DBMET03232 0.046 0.009 DBMET03233 0.034 0.024 DBMET03235 | DBMET03233 | |
| 0.037 | 0.042 | 0.04 | Phosphodiesterase 3B inhibitor | 0.04 0.036 DBMET03234 | DBMET03234 | |
| 0.044 | 0.051 | 0.058 | 5 Hydroxytryptamine 4 antagonist | 0.058 0.026 DBMET03234 | DBMET03234 | |
| 0.073 | 0.089 | 0.12 | Antihistaminic | 0.12 0.043 DBMET03234 | DBMET03234 | |
| 0.024 | 0.041 | 0.055 | Fumarate hydratase inhibitor | 0.048 0.014 DBMET03232 0.055 0.012 DBMET03233 | DBMET03233 | |
| 0.007 | 0.024 | 0.019 | Angiotensin AT1B receptor antagonist | 0.018 0.007 DBMET03232 0.019 0.006 DBMET03233 | DBMET03233 | |
| 0.011 | 0.028 | 0.015 | Adenosine A2 receptor agonist | 0.015 0.012 DBMET03230 | DBMET03230 | |
| 0.04 | 0.061 | 0.049 | GABA receptor antagonist | 0.049 0.046 DBMET03233 | DBMET03233 | |
| 0.126 | 0.148 | 0.192 | Lipocortins synthesis antagonist | 0.192 0.061 DBMET03232 0.187 0.066 DBMET03233 | DBMET03232 | |
| 0.077 | 0.101 | 0.233 | Expectorant | 0.233 0.015 DB12406 0.233 0.015 DBMET03229 0.193 0.022 DBMET03232 0.198 0.021 DBMET03233 0.198 0.021 DBMET03230 0.165 0.03 DBMET03231 0.138 0.04 DBMET03235 | DBMET03229 | |
| 0.062 | 0.089 | 0.105 | Histamine antagonist | 0.105 0.045 DBMET03234 | DBMET03234 | |
| 0.05 | 0.078 | 0.127 | Alpha 1 adrenoreceptor antagonist | 0.074 0.057 DB12406 0.074 0.057 DBMET03229 0.087 0.049 DBMET03234 0.127 0.035 DBMET03235 | DBMET03235 | |
| 0.045 | 0.077 | 0.089 | Alpha 1b adrenoreceptor antagonist | 0.068 0.054 DB12406 0.068 0.054 DBMET03229 0.064 0.058 DBMET03234 0.073 0.051 DBMET03230 0.089 0.04 DBMET03235 | DBMET03235 | |
| 0.007 | 0.038 | 0.014 | Purine nucleoside phosphorylase inhibitor | 0.011 0.01 DBMET03232 0.011 0.01 DBMET03233 0.013 0.006 DBMET03230 0.014 0.005 DBMET03235 | DBMET03235 | |
| 0.011 | 0.043 | 0.023 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.023 0.005 DBMET03234 0.021 0.006 DBMET03235 | DBMET03234 | |
| 0.023 | 0.059 | 0.038 | Purinergic P2X3 antagonist | 0.038 0.019 DB12406 0.038 0.019 DBMET03229 0.031 0.03 DBMET03232 0.034 0.024 DBMET03233 0.031 0.03 DBMET03230 0.037 0.02 DBMET03231 | DBMET03229 | |
| 0.125 | 0.167 | 0.584 | Aldehyde oxidase inhibitor | 0.33 0.059 DB12406 0.33 0.059 DBMET03229 0.19 0.11 DBMET03232 0.237 0.087 DBMET03233 0.266 0.076 DBMET03234 0.28 0.072 DBMET03230 0.33 0.059 DBMET03231 0.584 0.021 DBMET03235 | DBMET03235 | |
| 0.069 | 0.116 | 0.139 | Phosphodiesterase 7B inhibitor | 0.139 0.026 DBMET03234 0.117 0.04 DBMET03235 | DBMET03234 | |
| 0.055 | 0.106 | 0.138 | Alpha adrenoreceptor antagonist | 0.078 0.073 DB12406 0.078 0.073 DBMET03229 0.093 0.061 DBMET03234 0.138 0.041 DBMET03235 | DBMET03235 | |
| 0.033 | 0.083 | 0.062 | Argininosuccinate synthase inhibitor | 0.053 0.043 DBMET03232 0.062 0.035 DBMET03233 | DBMET03233 | |
| 0.035 | 0.088 | 0.152 | Biliverdin reductase inhibitor | 0.077 0.028 DB12406 0.077 0.028 DBMET03229 0.133 0.012 DBMET03232 0.152 0.009 DBMET03233 0.065 0.036 DBMET03230 0.077 0.028 DBMET03231 0.074 0.029 DBMET03235 | DBMET03233 | |
| 0.025 | 0.078 | 0.075 | Antimetabolite | 0.075 0.02 DBMET03232 0.07 0.022 DBMET03233 0.041 0.039 DBMET03234 0.058 0.026 DBMET03235 | DBMET03232 | |
| 0.121 | 0.175 | 0.144 | Ca2+-transporting ATPase inhibitor | 0.144 0.06 DBMET03232 0.14 0.073 DBMET03233 | DBMET03232 | |
| 0.14 | 0.198 | 0.182 | MAP kinase kinase 5 inhibitor | 0.182 0.059 DBMET03230 | DBMET03230 | |
| 0.035 | 0.101 | 0.116 | Phosphofructokinase-1 inhibitor | 0.116 0.026 DBMET03232 0.114 0.027 DBMET03233 0.072 0.046 DBMET03230 | DBMET03232 | |
| 0.116 | 0.183 | 0.181 | ATPase inhibitor | 0.181 0.057 DB12406 0.181 0.057 DBMET03229 0.152 0.098 DBMET03232 0.155 0.094 DBMET03233 0.163 0.081 DBMET03230 0.163 0.08 DBMET03231 | DBMET03229 | |
| 0.109 | 0.178 | 0.144 | CF transmembrane conductance regulator agonist | 0.13 0.119 DBMET03232 0.144 0.088 DBMET03233 0.133 0.112 DBMET03235 | DBMET03233 | |
| 0.151 | 0.222 | 0.261 | Gastrin inhibitor | 0.261 0.066 DBMET03232 0.252 0.076 DBMET03233 | DBMET03232 | |
| 0.051 | 0.125 | 0.183 | Antiadrenergic | 0.126 0.043 DB12406 0.126 0.043 DBMET03229 0.083 0.068 DBMET03234 0.109 0.05 DBMET03230 0.089 0.063 DBMET03231 0.183 0.028 DBMET03235 | DBMET03235 | |
| 0.011 | 0.087 | 0.018 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.015 DBMET03232 0.018 0.012 DBMET03233 | DBMET03233 | |
| 0.111 | 0.188 | 0.156 | Non-steroidal antiinflammatory agent | 0.146 0.12 DB12406 0.146 0.12 DBMET03229 0.156 0.107 DBMET03232 0.15 0.115 DBMET03233 0.152 0.112 DBMET03230 | DBMET03232 | |
| 0.061 | 0.137 | 0.088 | UDP-glucose 4-epimerase inhibitor | 0.088 0.076 DBMET03230 | DBMET03230 | |
| 0.104 | 0.181 | 0.136 | Sphingosine 1-phosphate receptor 5 antagonist | 0.136 0.088 DBMET03232 0.125 0.111 DBMET03233 | DBMET03232 | |
| 0.048 | 0.127 | 0.179 | Adrenaline antagonist | 0.12 0.043 DB12406 0.12 0.043 DBMET03229 0.08 0.068 DBMET03234 0.105 0.051 DBMET03230 0.085 0.064 DBMET03231 0.179 0.028 DBMET03235 | DBMET03235 | |
| 0.017 | 0.104 | 0.031 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.031 0.029 DBMET03232 | DBMET03232 | |
| 0.033 | 0.123 | 0.092 | Thromboxane synthase inhibitor | 0.092 0.008 DBMET03232 0.084 0.01 DBMET03233 0.055 0.037 DBMET03230 | DBMET03232 | |
| 0.02 | 0.109 | 0.074 | Alpha 1d adrenoreceptor antagonist | 0.074 0.033 DBMET03235 | DBMET03235 | |
| 0.028 | 0.125 | 0.085 | Cyclin B inhibitor | 0.085 0.014 DBMET03234 0.063 0.028 DBMET03235 | DBMET03234 | |
| 0.017 | 0.124 | 0.05 | Ornithine carbamoyltransferase inhibitor | 0.05 0.039 DBMET03232 0.048 0.041 DBMET03233 | DBMET03232 | |
| 0.022 | 0.133 | 0.068 | Alpha 1a adrenoreceptor antagonist | 0.068 0.052 DBMET03235 | DBMET03235 | |
| 0.01 | 0.123 | 0.028 | Protocollagen prolyl hydroxylase inhibitor | 0.026 0.021 DBMET03232 0.028 0.018 DBMET03233 | DBMET03233 | |
| 0.045 | 0.163 | 0.098 | ErbB-3 antagonist | 0.098 0.042 DBMET03232 0.094 0.045 DBMET03233 | DBMET03232 | |
| 0.078 | 0.197 | 0.128 | Neurotrophic factor | 0.128 0.083 DBMET03230 | DBMET03230 | |
| 0.026 | 0.15 | 0.072 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.072 0.025 DBMET03230 | DBMET03230 | |
| 0.049 | 0.179 | 0.064 | MDM2 inhibitor | 0.064 0.06 DBMET03233 | DBMET03233 | |
| 0.05 | 0.183 | 0.201 | Ferrochelatase inhibitor | 0.172 0.03 DBMET03232 0.201 0.022 DBMET03233 | DBMET03233 | |
| 0.023 | 0.19 | 0.042 | Glucagon-like peptide 1 receptor antagonist | 0.041 0.024 DBMET03232 0.042 0.023 DBMET03233 | DBMET03233 | |
| 0.016 | 0.188 | 0.038 | AMPA 4 receptor antagonist | 0.038 0.029 DBMET03232 0.037 0.032 DBMET03233 | DBMET03232 | |
| 0.035 | 0.208 | 0.088 | Alcohol dehydrogenase inhibitor | 0.088 0.066 DBMET03232 0.085 0.072 DBMET03233 0.083 0.075 DBMET03235 | DBMET03232 | |
| 0.122 | 0.295 | 0.221 | Peptidyltransferase inhibitor | 0.204 0.094 DB12406 0.204 0.094 DBMET03229 0.188 0.116 DBMET03232 0.198 0.102 DBMET03233 0.221 0.075 DBMET03230 0.204 0.094 DBMET03231 0.196 0.105 DBMET03235 | DBMET03230 | |
| 0.018 | 0.193 | 0.053 | AICAR transformylase inhibitor | 0.052 0.02 DBMET03232 0.053 0.019 DBMET03233 | DBMET03233 | |
| 0.043 | 0.222 | 0.101 | Cystathionine beta-synthase inhibitor | 0.101 0.076 DBMET03232 0.093 0.086 DBMET03233 | DBMET03232 | |
| 0.025 | 0.205 | 0.065 | Glutamate decarboxylase inhibitor | 0.065 0.062 DBMET03232 | DBMET03232 | |
| 0.082 | 0.264 | 0.188 | Platelet aggregation inhibitor | 0.188 0.09 DBMET03232 0.169 0.107 DBMET03233 | DBMET03232 | |
| 0.02 | 0.203 | 0.086 | Cyclin B1 inhibitor | 0.086 0.017 DBMET03234 0.077 0.025 DBMET03235 | DBMET03234 | |
| 0.015 | 0.202 | 0.077 | Cyclin B2 inhibitor | 0.077 0.017 DBMET03234 0.068 0.023 DBMET03235 | DBMET03234 | |
| 0.007 | 0.204 | 0.036 | Histamine H3 receptor agonist | 0.036 0.015 DBMET03234 0.024 0.023 DBMET03235 | DBMET03234 | |
| 0.038 | 0.236 | 0.082 | Prolactin inhibitor | 0.082 0.078 DBMET03232 | DBMET03232 | |
| 0.058 | 0.26 | 0.162 | EphB2 antagonist | 0.162 0.118 DBMET03234 | DBMET03234 | |
| 0.032 | 0.236 | 0.084 | Myeloperoxidase inhibitor | 0.084 0.06 DBMET03234 | DBMET03234 | |
| 0.075 | 0.281 | 0.138 | Adenylate cyclase stimulant | 0.138 0.086 DBMET03232 0.135 0.092 DBMET03233 0.128 0.107 DBMET03230 | DBMET03232 | |
| 0.003 | 0.212 | 0.014 | Egl nine homolog 1 inhibitor | 0.014 0.011 DBMET03233 | DBMET03233 | |
| 0.052 | 0.262 | 0.11 | Alpha 2d adrenoreceptor antagonist | 0.11 0.033 DBMET03234 0.1 0.048 DBMET03235 | DBMET03234 | |
| 0.042 | 0.252 | 0.107 | Alkylator | 0.107 0.081 DBMET03235 | DBMET03235 | |
| 0.15 | 0.36 | 0.441 | Cyclophilin D inhibitor | 0.394 0.094 DB12406 0.394 0.094 DBMET03229 0.435 0.073 DBMET03232 0.441 0.071 DBMET03233 0.372 0.108 DBMET03230 0.383 0.101 DBMET03231 0.32 0.146 DBMET03235 | DBMET03233 | |
| 0.07 | 0.285 | 0.164 | P-glycoprotein inhibitor | 0.164 0.097 DBMET03230 | DBMET03230 | |
| 0.067 | 0.317 | 0.326 | Insulin secretagoues | 0.326 0.01 DB12406 0.326 0.01 DBMET03229 0.204 0.034 DBMET03232 0.208 0.032 DBMET03233 0.257 0.018 DBMET03230 0.175 0.052 DBMET03231 0.236 0.022 DBMET03235 | DBMET03229 | |
| 0.06 | 0.327 | 0.324 | Platelet antagonist | 0.324 0.045 DBMET03232 0.304 0.051 DBMET03233 | DBMET03232 | |
| 0.034 | 0.301 | 0.122 | Cell adhesion molecule inhibitor | 0.117 0.025 DBMET03232 0.122 0.023 DBMET03233 | DBMET03233 | |
| 0.032 | 0.3 | 0.191 | GABA C receptor agonist | 0.167 0.028 DBMET03232 0.191 0.022 DBMET03233 | DBMET03233 | |
| 0.115 | 0.384 | 0.206 | Tyrosine 3 hydroxylase inhibitor | 0.191 0.152 DBMET03232 0.206 0.125 DBMET03233 | DBMET03233 | |
| 0.048 | 0.325 | 0.09 | Hematopoietic | 0.09 0.049 DBMET03232 0.087 0.055 DBMET03233 0.08 0.074 DBMET03230 | DBMET03232 | |
| 0.043 | 0.325 | 0.095 | Nav1.1 sodium channel blocker | 0.091 0.079 DB12406 0.091 0.079 DBMET03229 0.095 0.072 DBMET03235 | DBMET03235 | |
| 0.106 | 0.392 | 0.323 | Histamine release inhibitor | 0.235 0.167 DB12406 0.235 0.167 DBMET03229 0.321 0.113 DBMET03232 0.323 0.112 DBMET03233 0.256 0.151 DBMET03230 0.28 0.135 DBMET03235 | DBMET03233 | |
| 0.063 | 0.358 | 0.215 | Growth hormone agonist | 0.215 0.053 DBMET03232 0.184 0.066 DBMET03233 0.132 0.104 DBMET03235 | DBMET03232 | |
| 0.034 | 0.341 | 0.161 | Nav1.3 sodium channel blocker | 0.161 0.041 DBMET03235 | DBMET03235 | |
| 0.051 | 0.372 | 0.222 | Interleukin agonist | 0.209 0.113 DB12406 0.209 0.113 DBMET03229 0.222 0.101 DBMET03232 0.207 0.114 DBMET03233 0.222 0.101 DBMET03231 0.186 0.134 DBMET03235 | DBMET03231 | |
| 0.041 | 0.37 | 0.203 | MAP kinase kinase 2 inhibitor | 0.203 0.08 DBMET03230 | DBMET03230 | |
| 0.073 | 0.405 | 0.181 | Transcription factor STAT inhibitor | 0.181 0.166 DB12406 0.181 0.166 DBMET03229 | DBMET03229 | |
| 0 | 0.345 | 0.012 | Mannitol 2-dehydrogenase inhibitor | 0.012 0.004 DBMET03230 | DBMET03230 | |
| 0.083 | 0.445 | 0.19 | Insulysin inhibitor | 0.19 0.172 DBMET03233 | DBMET03233 | |
| 0.018 | 0.38 | 0.081 | Adrenaline agonist | 0.081 0.057 DBMET03235 | DBMET03235 | |
| 0.027 | 0.39 | 0.12 | MAP kinase kinase 1 inhibitor | 0.12 0.035 DBMET03230 | DBMET03230 | |
| 0.008 | 0.395 | 0.047 | Mannosidase inhibitor | 0.047 0.029 DBMET03230 | DBMET03230 | |
| 0.016 | 0.448 | 0.154 | MAP kinase kinase inhibitor | 0.154 0.049 DBMET03230 | DBMET03230 | |
| 0.063 | 0.497 | 0.248 | Growth factor agonist | 0.248 0.033 DBMET03231 | DBMET03231 | |
| 0.031 | 0.471 | 0.132 | Cell adhesion inhibitor | 0.129 0.059 DBMET03232 0.132 0.058 DBMET03233 | DBMET03233 | |
| 0.003 | 0.451 | 0.039 | Renin inhibitor | 0.039 0.023 DBMET03231 | DBMET03231 | |
| 0.065 | 0.702 | 0.309 | Interleukin 2 agonist | 0.208 0.176 DB12406 0.208 0.176 DBMET03229 0.24 0.13 DBMET03232 0.214 0.166 DBMET03233 0.216 0.163 DBMET03230 0.309 0.067 DBMET03231 0.225 0.149 DBMET03235 | DBMET03231 | |
| 0.048 | 0.688 | 0.17 | Catenin beta inhibitor | 0.164 0.076 DBMET03232 0.17 0.066 DBMET03233 | DBMET03233 | |
| 0.007 | 0.683 | 0.051 | Sphingosine 1-phosphate receptor 5 agonist | 0.051 0.045 DBMET03232 | DBMET03232 | |
| 0.022 | 0.777 | 0.174 | Hypoglycemic | 0.174 0.141 DBMET03230 | DBMET03230 | |
| 0.028 | 0.801 | 0.095 | Folate antagonist | 0.095 0.074 DBMET03232 0.093 0.078 DBMET03233 | DBMET03232 | |
| 0.003 | 0.781 | 0.034 | HMG CoA reductase inhibitor | 0.034 0.024 DBMET03230 | DBMET03230 | |
| 0.009 | 0.891 | 0.25 | Aurora-C kinase inhibitor | 0.25 0.009 DBMET03231 | DBMET03231 | |
| 0.006 | 0.909 | 0.07 | Prostaglandin F2 alpha antagonist | 0.07 0.032 DBMET03230 | DBMET03230 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |